PL1948216T3 - Leczenie ostrej niewydolności nerek za pomocą rozpuszczalnej trombomoduliny - Google Patents

Leczenie ostrej niewydolności nerek za pomocą rozpuszczalnej trombomoduliny

Info

Publication number
PL1948216T3
PL1948216T3 PL06825898T PL06825898T PL1948216T3 PL 1948216 T3 PL1948216 T3 PL 1948216T3 PL 06825898 T PL06825898 T PL 06825898T PL 06825898 T PL06825898 T PL 06825898T PL 1948216 T3 PL1948216 T3 PL 1948216T3
Authority
PL
Poland
Prior art keywords
soluble thrombomodulin
renal failure
acute renal
treatment
thrombomodulin
Prior art date
Application number
PL06825898T
Other languages
English (en)
Inventor
Brian William Grinnell
Thurman Dwight Mckinney
Bruce A Molitoris
Original Assignee
Lilly Co Eli
Univ Indiana Res & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Indiana Res & Tech Corp filed Critical Lilly Co Eli
Publication of PL1948216T3 publication Critical patent/PL1948216T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06825898T 2005-10-13 2006-10-12 Leczenie ostrej niewydolności nerek za pomocą rozpuszczalnej trombomoduliny PL1948216T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72637605P 2005-10-13 2005-10-13
PCT/US2006/040069 WO2007047430A2 (en) 2005-10-13 2006-10-12 Method of treating acute failure with thrombomodulin variant
EP06825898A EP1948216B1 (en) 2005-10-13 2006-10-12 Treatment of acute renal failure with soluble thrombomodulin

Publications (1)

Publication Number Publication Date
PL1948216T3 true PL1948216T3 (pl) 2011-10-31

Family

ID=37670944

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06825898T PL1948216T3 (pl) 2005-10-13 2006-10-12 Leczenie ostrej niewydolności nerek za pomocą rozpuszczalnej trombomoduliny

Country Status (13)

Country Link
US (1) US20080255047A1 (pl)
EP (1) EP1948216B1 (pl)
JP (1) JP5405829B2 (pl)
AT (1) ATE503489T1 (pl)
CA (1) CA2625888C (pl)
CY (1) CY1112438T1 (pl)
DE (1) DE602006021048D1 (pl)
DK (1) DK1948216T3 (pl)
ES (1) ES2360610T3 (pl)
PL (1) PL1948216T3 (pl)
PT (1) PT1948216E (pl)
SI (1) SI1948216T1 (pl)
WO (1) WO2007047430A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2671863C (en) * 2006-12-12 2015-07-21 Eli Lilly And Company Method of treating acute renal failure with thrombomodulin variants
CA2743141A1 (en) * 2008-11-12 2010-05-20 Eli Lilly And Company Compositions and methods of use for soluble thrombomodulin variants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
PT641215E (pt) * 1992-02-05 2004-09-30 Paion Gmbh Analogos de trombomodulina resistentes a proteases
US5834028A (en) * 1993-12-17 1998-11-10 Mochida Pharmaceutical Co., Ltd. Soluble thrombomodulin-containing composition
CA2515916A1 (en) * 2003-02-25 2004-09-10 Biovec B.V. Therapeutic applications of thrombomodulin gene via viral and non-viral vectors

Also Published As

Publication number Publication date
JP5405829B2 (ja) 2014-02-05
EP1948216B1 (en) 2011-03-30
WO2007047430A8 (en) 2008-04-10
EP1948216A2 (en) 2008-07-30
DK1948216T3 (da) 2011-06-06
PT1948216E (pt) 2011-05-06
WO2007047430A3 (en) 2007-05-24
WO2007047430A2 (en) 2007-04-26
ATE503489T1 (de) 2011-04-15
JP2009511597A (ja) 2009-03-19
CA2625888C (en) 2015-09-22
DE602006021048D1 (de) 2011-05-12
US20080255047A1 (en) 2008-10-16
SI1948216T1 (sl) 2011-07-29
ES2360610T3 (es) 2011-06-07
CA2625888A1 (en) 2007-04-26
CY1112438T1 (el) 2015-12-09

Similar Documents

Publication Publication Date Title
IL160420A0 (en) Treating or preventing diabetes with cannabidiol
CY1116160T1 (el) Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
EA201290041A1 (ru) Лечение расстройств, связанных с макрофагами
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
UA100111C2 (ru) Лечение диабета типа 2 комбинацией ингибитора dpiv и метформина или тиазолидиндиона
WO2007038768A3 (en) Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
PT1809661E (pt) Muteína do interferão beta humano
CO6260015A2 (es) Metodos y tratamiento para la dependencia, mediante la administracion de un agente psicoestimulante, un opiode y otros
PL1919466T3 (pl) Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
WO2005097187A3 (en) Methods of preventing uvb-induced skin damage
HK1121083A1 (en) Methods for reducing blood pressure
MY140538A (en) Substituted n-acyl-2-aminothiazoles
EP2754447A3 (en) Treating acute renal failure with soluble thrombomodulin variants
SI1948216T1 (sl) Zdravljenje akutne ledviäśne odpovedi s topnim trombomodulinom
WO2009006246A8 (en) Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
PT1670489E (pt) Utilização de xénon com hipotermia para o tratamento de asfixia neonatal
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
TN2011000206A1 (en) Compositions and methods of use soluble thrombomodulin variants
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders
WO2008033368A3 (en) Boroproline compound and cytokine combination therapy
TW200640484A (en) Treatment of brain tissue damage
WO2007017652A3 (en) Arylakylamines for the treatment of cancer